 Home > Medical News > Latest Medical News > BeiGene's CD3/CD19 Dual Antibody Belintoumumab New Indication Approved

BeiGene's CD3/CD19 Dual Antibody Belintoumumab New Indication Approved

 Last Update: 2022-05-14
 Source: Internet
 Author: User

Tags

blood cell chart

cell lysis protocol

Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

Article source: Medical Cube Info

Author: info

On April 29, BeiGene's new indication of belintoumumab for injection submitted by BeiGene was approved by the State Food and Drug Administration for the treatment of relapsed or refractory precursor B-cell acute lymphoblastic leukemia in adults and children

Belintuumab is a CD3-CD19-targeting bispecific antibody developed based on Amgen's state-of-the-art Bispecific T Cell Engagement System (BiTE®)

Belintuumab was approved by the NMPA on December 4 last year through priority review for the treatment of adults with relapsed or refractory precursor B-cell acute lymphoblastic leukemia (ALL)

Belintoumumab was first approved by the FDA in December 2014

This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

Related Products

L-Ascorbate-2-Monophosphate Feed Grade

CAS No.: 109620-90-8

Feed Grade

Potassium Sorbate from reliable manufacturer

CAS No.: 590-00-1

Food Grade

Doxycycline Hydrochloride

CAS No.: 10592-13-9

Pharmaceutical Grade

Hot Tags

united states jobs(223)

jobs united states(236)

1 year treasury(277)

1 year subscription(296)

announcements today(81)

80 20 company(94)

united states logo(227)

single use technology(195)

healthy food name(42)

ups united states(221)

Hot Articles

The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.